Phäochromozytom – Sekundäre Hypertonie von Amy Sussman, MD

video locked

Über den Vortrag

Der Vortrag „Phäochromozytom – Sekundäre Hypertonie“ von Amy Sussman, MD ist Bestandteil des Kurses „Sekundäre Hypertonie“.


Quiz zum Vortrag

  1. Multiple endocrine neoplasia type 2 (MEN2)
  2. Neurofibromatosis type 2
  3. Multiple endocrine neoplasia type 1 (MEN1)
  4. Tuberous sclerosis
  1. Starting a beta-blocker before adequate alpha blockade can lead to a further elevation in blood pressure.
  2. Nitroprusside is the preferred drug for preoperative blood pressure control in patients with pheochromocytoma.
  3. MIBG scintigraphy should be performed when CT or MRI findings are negative after a negative biochemical test result.
  4. A fractionated plasma metanephrine test has the highest sensitivity and specificity among the biochemical tests used in pheochromocytoma.
  1. A catecholamine-secreting tumor arising from chromaffin cells from the adrenal medulla and the sympathetic ganglia.
  2. A neuroendocrine tumor arising from primitive cells of the gut and lung.
  3. A vasoactive intestinal peptide-secreting tumor that typically arises from pancreatic islet cells.
  4. An insulin-secreting tumor arising from the ductular/acinar system of the pancreas.

Dozent des Vortrages Phäochromozytom – Sekundäre Hypertonie

 Amy Sussman, MD

Amy Sussman, MD

Dr. Amy Sussman is an Associate Professor of Medicine and the Vice Chair of Education in the Department of Medicine of the University of Arizona (UA), USA.
She obtained her MD from the University of Arizona in 2001 and completed residency and a Nephrology Fellowship at the University of Washington. Dr. Sussman was recruited back to the UA in 2009 and also serves as her department's clerkship director, and as the program director of the UA Nephrology Fellowship.
Because of her strong emphasis on medical student teaching, she has been distinguished with multiple teaching awards in the UA College of Medicine.
Within Lecturio, Dr. Sussman teaches courses on Nephrology.


Kundenrezensionen

(1)
5,0 von 5 Sternen
5 Sterne
5
4 Sterne
0
3 Sterne
0
2 Sterne
0
1  Stern
0